PS
Poulton Stuart
Directeur du Développement
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Poulton Stuart, Directeur du Développement. Insider active across 1 company, notably Karyopharm Therapeutics Inc.. In total, 19 filings have been recorded. Breakdown: 0 buy · 11 sells. Total volume traded: €119k. Activity tracked since 15 February 2023. The latest transaction was disclosed on 28 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Poulton Stuart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
189 股@ US$7.100.0030% mcap1.0% 占其流量Common StockSEC:0001193125-26-326290:0
896 股0Common StockSEC:0001193125-26-226697:0
5,101 股@ US$9.409534.6% 占其流量Common StockSEC:0001942597-26-000003:0
378 股@ US$8.632.3% 占其流量Common StockSEC:0001193125-26-059332:0
32,415 股0Common StockSEC:0001193125-26-035655:0
39,682 股0Common StockSEC:0001193125-25-241484:0
888 股0Common StockSEC:0001193125-25-205046:0
191 股@ US$4.371.0% 占其流量Common StockSEC:0000950170-25-100373:0
3,548 股@ US$6.2928.9% 占其流量Common StockSEC:0000950170-25-034723:0
5,000 股0Common StockSEC:0000950170-25-032309:0
5,914 股@ US$0.634.8% 占其流量Common StockSEC:0000950170-25-023192:0
2,883 股@ US$1.063.8% 占其流量Common StockSEC:0000950170-24-088589:0
16,311 股@ US$1.1723.9% 占其流量CommonSEC:0000950170-24-025192:0
188,205 股0Common StockSEC:0000950170-24-023293:0
5,748 股@ US$1.339.7% 占其流量Common StockSEC:0000950170-24-017237:0
13,333 股0Common StockSEC:0000950170-24-007610:0
2,845 股@ US$1.706.0% 占其流量Common StockSEC:0001209191-23-044040:0
95,000 股0Common StockSEC:0001209191-23-014872:0
5,665 股@ US$3.1922.9% 占其流量Common StockSEC:0001209191-23-010509:0
About Poulton Stuart
Poulton Stuart is Directeur du Développement and EVP, Chief Development Officer at Karyopharm Therapeutics Inc. The 18 filings recorded, all in the recent filing sample, cover the period from 2023-02-17 to 2026-05-15 and consist only of sales, for total sales of EUR 117924.